journal article·2017-04-03Open access

Acyclovir-loaded sorbitan esters-based organogel: development and rheological characterization

Kuldeep Rajpoot

Abstract

Herein, a nanoemulsion-based organogel (NEOG) system loaded with acyclovir has been developed for the effective treatment of herpes simplex virus infection via topical delivery. Pseudo-ternary phase diagram exhibited increase in non-birefrigent, optically isotropic region of organogel with Smix (Kw) ratio. The NEOG C showed good storage (G′) and loss moduli (G″), and more compact network structures. Gel-sol transition temperature (Tg) and fractal dimension (Df) of NEOG system revealed increased density of the tubular network with Kw. Hence, high gelling ability of the developed NEOG system may attribute to the combination of sustained and site-specific delivery of drugs.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Supramolecular Self-Assembly in Materials · Advanced Drug Delivery Systems · Ocular Surface and Contact Lens

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Pharmaceutical Research Project Laboratory, Department of Pharmaceutical Sciences, Dr. Hari Singh Gour Vishwavidyalaya, Sagar, Madhya Pradesh, India;

Pharmaceutical Research Project Laboratory, Institute of Pharmaceutical Sciences, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur, Chhattisgarh, India

References (41)

Show source-provided references
1. 10.1016/0168-3659(96)01369-710.1016/0168-3659(96)01369-7 ↗
2. 10.1097/OLQ.0b013e31823b50c610.1097/OLQ.0b013e31823b50c6 ↗
3. 10.1016/j.jchromb.2004.11.03810.1016/j.jchromb.2004.11.038 ↗
4. Boddu SH · Int J Pharm Compd · 2014 · 18 · 256
5. Bramwell BL · Int J Pharm Compd · 2012 · 16 · 62
6. 10.1056/NEJM19830421308160210.1056/NEJM198304213081602 ↗
7. 10.1097/00006454-199807000-0001010.1097/00006454-199807000-00010 ↗
8. 10.1016/0002-9343(82)90072-910.1016/0002-9343(82)90072-9 ↗
9. 10.1093/jac/12.suppl_B.2910.1093/jac/12.suppl_B.29 ↗
10. 10.1016/j.rvsc.2015.01.00910.1016/j.rvsc.2015.01.009 ↗
11. 10.1002/jmr.83110.1002/jmr.831 ↗
12. 10.1089/jop.2010.018810.1089/jop.2010.0188 ↗
13. 10.1016/S0168-3659(99)00092-910.1016/S0168-3659(99)00092-9 ↗
14. 10.1016/0166-3542(83)90004-910.1016/0166-3542(83)90004-9 ↗
15. 10.1111/ics.1213110.1111/ics.12131 ↗
16. 10.1016/j.cis.2006.05.01410.1016/j.cis.2006.05.014 ↗
17. 10.1016/0168-3659(90)90164-O10.1016/0168-3659(90)90164-O ↗
18. 10.1039/c3cc43320j10.1039/c3cc43320j ↗
19. 10.1016/S0140-6736(81)92569-110.1016/S0140-6736(81)92569-1 ↗
20. 10.1016/j.ijbiomac.2005.03.01210.1016/j.ijbiomac.2005.03.012 ↗
21. Monavari SH · Med J Islam Repub Iran · 2014 · 28 · 99
22. 10.1016/S0378-5173(99)00042-310.1016/S0378-5173(99)00042-3 ↗
23. 10.1021/js980342r10.1021/js980342r ↗
24. 10.1021/js980343j10.1021/js980343j ↗
25. 10.1021/ma00202a05010.1021/ma00202a050 ↗
26. Panigrahi L · AAPS PharmSciTech · 2005 · 6 · E16710.1208/pt060225 ↗
27. Peacock GF · Int J Pharm Compd · 2014 · 18 · 348
28. 10.1016/S0378-5173(97)00358-X10.1016/S0378-5173(97)00358-X ↗
29. 10.1016/0260-8774(94)90030-210.1016/0260-8774(94)90030-2 ↗
30. Pisal S · AAPS PharmSciTech · 2004 · 5 · e6310.1208/pt050459 ↗
31. Quellet C · Chimia · 1986 · 40 · 23310.2533/chimia.1986.233 ↗
32. 10.1016/0168-3659(87)90035-610.1016/0168-3659(87)90035-6 ↗
33. 10.1002/elps.20100032810.1002/elps.201000328 ↗
34. 10.1016/j.jmbbm.2014.11.02610.1016/j.jmbbm.2014.11.026 ↗
35. 10.1016/0378-5173(84)90090-510.1016/0378-5173(84)90090-5 ↗
36. 10.3109/03639045.2013.85071110.3109/03639045.2013.850711 ↗
37. 10.1021/j100314a04710.1021/j100314a047 ↗
38. 10.1016/j.suponc.2011.10.00610.1016/j.suponc.2011.10.006 ↗
39. 10.1080/0363904070119926610.1080/03639040701199266 ↗
40. 10.2165/00003495-199447010-0000910.2165/00003495-199447010-00009 ↗
41. 10.1021/jf300609p10.1021/jf300609p ↗